FindTrial
Sign In

A split face randomized control study to compare efficacy and safety of Carbon Dioxide laser treatment versus Radiofrequency ablation in facial angiofibromas of Tuberous sclerosis

A split face randomized control study comparing the efficacy and safety of Carbon Dioxide laser treatment versus Radiofrequency ablation in the treatment of facial angiofibromas in patients of Tuberous sclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/02/007830
Enrollment
59
Registered
2017-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Facial angiofibroma in patients with tuberous sclerosis

Interventions

Intervention1: carbon di oxide laser: CO2 laser will be done in one side of face. Control Intervention1: radiofrequency ablation: RFA will done in other side of face

Sponsors

AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age > 12 years Patients with clinical diagnosis of tuberous sclerosis according to clinical criteria by 2012 International Tuberous Sclerosis Complex Consensus Conference with multiple facial angiofibromas present bilaterally.

Exclusion criteria

Exclusion criteria: Patients with uncontrolled seizures. Photosensitive disorders Cardiac pacemakers Metallic implants

Design outcomes

Primary

MeasureTime frame
1. Subjective assessment by patient Patients will score the treatment response from grade 1-5. 2. Physician assessment by photographic comparison. Timepoint: month 1,3,6—

Secondary

MeasureTime frame
adverse eventsTimepoint: week1, montrh 1,3.6—

Countries

India

Contacts

Public ContactDr Suman Patra

AIIMS

patrohere@gmail.com9650450413

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026